SCHEMBL22489835

SCHEMBL22489835

COc1cnccc1-c1cccc(C(C)(C)N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 4/20 0.46
CYP1A2 P05177 2/20 0.43
METAP2 P50579 1/20 0.43
KIF11 P52732 1/20 0.42
DYRK1A Q13627 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
PTPN5 P54829 1/20 0.41
GPBAR1 Q8TDU6 1/20 0.40
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
PRKCQ Q04759 1/20 0.39
RPS6KA3 P51812 1/20 0.39
MGAT2 Q10469 1/20 0.39
CYP1A1 P04798 1/20 0.39
CYP2E1 P05181 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2A6 P11509 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22489779 0.81 CYP17A1 (0.46) CYP1A2METAP2KIF11DYRK1AGPBAR1
SCHEMBL18676839 0.78 RPS6KA3 (0.52) AAK1CYP1A2MKNK1MKNK2RPS6KA3
SCHEMBL22489864 0.78 CCNC (0.44) KIF11PTPN5GPBAR1PRKCQCYP17A1
SCHEMBL22489834 0.77 ROCK2 (0.44) AAK1MKNK1MKNK2PTPN5GPBAR1
SCHEMBL22466987 0.75 ALOX5AP (0.41) AAK1MKNK1MKNK2PTPN5ATR
SCHEMBL22489776 0.75 AAK1 (0.48) AAK1CYP1A2DYRK1AMKNK1MKNK2
SCHEMBL22489888 0.75 TSHR (0.47) GPBAR1AKR1C3AKR1C2
SCHEMBL18674297 0.74 HDAC4 (0.46) AAK1CYP1A2DYRK1AMKNK1MKNK2
Hydrochloric Acid SCHEMBL22467248 0.74 AAK1 (0.47) AAK1CYP1A2DYRK1AMKNK1MKNK2
Hydrochloric Acid SCHEMBL22467251 0.74 AAK1 (0.47) AAK1CYP1A2DYRK1AMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11236055-B2 Non-systemic TGR5 agonists Venenum Biodesign, LLC (US) 2022-02-01 US disclosed
US-20200308122-A1 NOVEL NON-SYSTEMIC TGR5 AGONISTS Venenum Biodesign, LLC (US) 2020-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308122-A1 NOVEL NON-SYSTEMIC TGR5 AGONISTS GPR119, SSTR5, FFAR3 AAK1 2445/4885CYP1A2 2095/4885METAP2 1767/4885
US-11236055-B2 Non-systemic TGR5 agonists SSTR5, GPR119, FFAR3 AAK1 2654/4885CYP1A2 1864/4885METAP2 1499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.